Stericycle reports Q2 adjusted EPS 43c, consensus 49c

Reports Q2 revenue $669.5M, consensus $683.48M. “In the second quarter, we achieved our key business priority of lowering our debt leverage ratio below 3.0X and to the lowest level since 2015. We also made significant progress in executing our portfolio optimization by exiting businesses in four countries and we remain on track to deploy the ERP to U.S. RWCS in the third quarter,” said Cindy J. Miller, President and Chief Executive Officer. “Our first half financial performance came in line with our full-year 2023 guidance, which we are reaffirming.”